MYL

Mylan Inc. News Headlines

$45.79
*  
0.50
1.08%
Get MYL Alerts
*Delayed - data as of Sep. 29, 2014  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pfizer Acquires InnoPharma, Injectables Business to Benefit - Analyst Blog
9/26/2014 4:20:00 PM - Zacks.com

Indian Shares Marginally Lower In Early Trade
9/26/2014 12:33:00 AM - RTT News

Dr. Reddy's (RDY) Generic Xopenex Launched in the US - Analyst Blog
9/25/2014 6:19:00 PM - Zacks.com

Is It Time to Buy Dividend Stock Teva Pharmaceutical Industries Ltd?
9/25/2014 9:01:03 AM - Motley Fool

Will New Treasury Rules Contain Tax Inversions? - Analyst Blog
9/24/2014 10:22:00 AM - Zacks.com

Nasdaq 100 Movers: MYL, BIDU
9/23/2014 12:17:56 PM - BNK Invest

Stocks Fall For U.S. Firms in Pending Inversion Deals After Treasury Move -- Update
9/23/2014 11:48:00 AM - Dow Jones Business News

Stocks Fall For U.S. Firms in Pending Inversion Deals
9/23/2014 11:45:00 AM - Dow Jones Business News

Stocks Fall For U.S. Firms in Pending Inversion Deals After Treasury Move
9/23/2014 11:33:00 AM - Dow Jones Business News

What Makes Mylan Attractive
9/18/2014 8:36:00 AM - Seeking Alpha

VOE, MYL, STX, UAL: Large Inflows Detected at ETF
9/17/2014 11:10:37 AM - BNK Invest

Gilead (GILD) Slips on Generic Sovaldi Licensing Deals - Analyst Blog
9/16/2014 4:45:00 PM - Zacks.com

3 Reasons Dividend Stock Teva Pharmaceutical Industries Ltd. Could Fall
9/16/2014 11:52:19 AM - Motley Fool

Mylan To Commence Phase III Trial For Its Generic Version Of Advair Diskus
9/16/2014 7:40:00 AM - RTT News

MYL January 2017 Options Begin Trading
9/15/2014 1:12:08 PM - BNK Invest

Sector Update: Health-Care Shares Flat Pre-Market
9/15/2014 8:04:53 AM - MT Newswires

Sector Update: Health Care
9/15/2014 8:04:38 AM - MT Newswires

Mylan Signs Deal With Gilead Sciences On Sovaldi And Ledipasvir/Sofosbuvir
9/15/2014 6:42:00 AM - RTT News

Mylan to Acquire U.S. Rights to Arixtra for up to $300M - Analyst Blog
9/11/2014 5:20:00 PM - Zacks.com

Strong Portfolio Will Drive Growth For Mylan
9/11/2014 4:42:00 PM - Seeking Alpha

Sector Update: Health-Care Shares Mixed Ahead of Opening Bell
9/10/2014 9:14:41 AM - MT Newswires

Sector Update: Health Care
9/10/2014 9:13:41 AM - MT Newswires

Mylan To Acquire U.S. Rights To Aritxtra Injection From Aspen Global
9/10/2014 8:43:00 AM - RTT News

Mylan Unit To Acquire U.S. Commercialization Rights Relating To Arixtra
9/10/2014 7:18:00 AM - RTT News

Hospira Down on Legal Blow; Court Allows Generic Precedex - Analyst Blog
9/9/2014 4:45:00 PM - Zacks.com